While hospital fundamentals remain solid for 2025, BofA expects investor sentiment to weaken in the second half of this year as attention shifts to the longer-term impact. The bill is projected to ...

It is hard to get excited after looking at UnitedHealth Group's (NYSE:UNH) recent performance, when its stock has declined 50 ...

Shares have cratered since April, when the company slashed its financial guidance and posted earnings that missed ...

UnitedHealth’s July 29 earnings report is a pivotal moment for the stock after a 40% plunge, with analysts still optimistic ...

Wolfe Research reaffirmed its ‘Outperform’ rating on UnitedHealth Group but cut its price target to $330 from $363, citing ongoing medical billing pressures. The firm highlighted that UnitedHealth’s ...

UnitedHealth continues to face headwinds due to regulatory scrutiny, Medicare costs, and management changes. Read more on ...

UnitedHealth's management has already signaled an improving outlook for the second half of 2025. Click here to read an ...

UnitedHealth Group is juggling regulatory headaches and financial setbacks while trying to pivot back to stability and growth ...

UnitedHealth Group Inc. UNH is currently navigating a challenging healthcare landscape, with its Medicare Advantage business ...

According to a SEC filing dated July 10, Ferguson Wellman Capital Management sold 155,436 shares of UnitedHealth Group( UNH ...

A significant trading signal occurred for UnitedHealth stock, as it demonstrated a power inflow at $299.78, after which UNH ...

Discover the factors behind UnitedHealth's recent stock plunge and what it means for investors. Is UNH still a viable ...